Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Class A Common Shares
-
Shares outstanding
-
98,656,192
-
Total 13F shares
-
6,466,600
-
Share change
-
-361,716
-
Total reported value
-
$11,532,275
-
Put/Call ratio
-
0%
-
Price per share
-
$1.81
-
Number of holders
-
32
-
Value change
-
+$17,221
-
Number of buys
-
10
-
Number of sells
-
10
Institutional Holders of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) as of Q1 2024
As of 31 Mar 2024 Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) had 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,466,600 shares of stock of the company.
Largest 10 holders included MMCAP International Inc. SPC, Tejara Capital Ltd, AdvisorShares Investments LLC, Lion Street Advisors, LLC, Cambridge Investment Research Advisors, Inc., MGO ONE SEVEN LLC, Laird Norton Wetherby Trust Company, LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, and BANK OF MONTREAL /CAN/.
This table shows 32 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.